News Releases

January 13, 2020 at 7:50 AM EST

Summary Toggle Assertio Therapeutics Announces Closing of Gralise® Sale to Alvogen and Expects Full-Year 2019 Neurology Franchise Net Sales Above Upper End of Prior Guidance

LAKE FOREST, Ill. , Jan. 13, 2020 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (“Assertio” or “The Company”) (NASDAQ: ASRT), today announced the closing of its previously disclosed agreement (“Agreement”) with Alvogen , a global privately held pharmaceutical company, under which Alvogen will
December 12, 2019 at 7:50 AM EST

Summary Toggle Assertio Therapeutics Announces Sale of Gralise® for Total Transaction Value of $127.5 Million

LAKE FOREST, Ill. , Dec. 12, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (“Assertio”) (NASDAQ: ASRT), today announced it has entered into an agreement with Alvogen , a global privately held pharmaceutical company, under which Alvogen will acquire and assume all responsibilities associated
November 26, 2019 at 2:28 PM EST

Summary Toggle Assertio Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare Conference

LAKE FOREST, Ill. , Nov. 26, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the 31 st Annual Piper Jaffray Healthcare Conference in a session scheduled for 9:30 a.m.
November 13, 2019 at 12:58 PM EST

Summary Toggle Assertio Therapeutics to Present at the 2019 Stifel Healthcare Conference

LAKE FOREST, Ill. , Nov. 13, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the Stifel Healthcare Conference in a session scheduled for 10:20 a.m. ET , Wednesday, November 20, 2019 in New York, NY.
November 6, 2019 at 4:05 PM EST

Summary Toggle Assertio Therapeutics Announces Third-Quarter 2019 Results

-- Company Implements New Cost Savings Initiatives Expected to Deliver Annualized Savings of $20.0 Million -- -- Raises Full-Year 2019 Earnings Guidance Ranges -- -- Lowers Full-Year 2019 Neurology Franchise Net Sales Guidance -- -- Reduces Total Debt by $200.0 Million Year to Date -- -- Extends
October 23, 2019 at 9:05 AM EDT

Summary Toggle Assertio Therapeutics to Report Third-Quarter 2019 Financial Results After the Close of Markets on Wednesday, November 6, 2019

LAKE FOREST, Ill. , Oct. 23, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that it will release third-quarter 2019 financial results on Wednesday, November 6, 2019 , after the close of markets. Following the announcement, the Company will host a conference call
October 21, 2019 at 9:05 AM EDT

Summary Toggle Assertio Therapeutics Provides Regulatory Update on Long-Acting Cosyntropin

LAKE FOREST, Ill. , Oct. 21, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), today announced that its development partner West Therapeutic Development, LLC (West) has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration ( FDA ) for its New Drug
September 30, 2019 at 12:35 PM EDT

Summary Toggle Assertio Therapeutics Announces Appointment of Dr. David Wheadon to its Board of Directors

LAKE FOREST, Ill. , Sept. 30, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) announced today that Dr. David Wheadon has been appointed to the Company’s Board of Directors. Dr. Wheadon is a former senior executive of AstraZeneca plc .
September 26, 2019 at 8:00 AM EDT

Summary Toggle Assertio Therapeutics to Present at the Annual Cantor Fitzgerald Global Healthcare Conference

LAKE FOREST, Ill. , Sept. 26, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the Annual Cantor Fitzgerald Global Healthcare Conference in a session scheduled for 12:35 p.m.
August 20, 2019 at 8:00 AM EDT

Summary Toggle Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference

LAKE FOREST, Illinois , Aug. 20, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the 17 th Annual Morgan Stanley Global Healthcare Conference in a session scheduled for 11:45 a.m.